Johnson FR, Hauber BHIV, Ozdemir S, Hass S, Seigel C, Sands B. Quantitative benefit-risk tradeoff preferences for crohn's disease treatment - Implications for regulatory decision making and disease management. Crohn's disease: etiology, pathogenesis and interventions. 2009;15(5/6):456-66.


Abstract not available at this time.

Share on: